Monitor for any reverse stock split announcement or capital raise plan, as these are common remedies for bid price compliance. The company's ability to regain compliance by March 16, 2027 is uncertain without a catalyst to lift the stock price above $1.00.
Price Chart
Executive Summary
Filana Therapeutics received a Nasdaq deficiency notice on September 17, 2026, because its common stock bid price closed below $1.00 per share for 30 consecutive business days, violating Listing Rule 5550(a)(2). The company has 180 calendar days (until March 16, 2027) to regain compliance by closing at or above $1.00 for at least 10 consecutive business days. Failure to cure could lead to delisting, which would severely reduce institutional ownership and liquidity.
Key Facts
- Nasdaq deficiency notice received September 17, 2026 for bid price below $1.00 for 30 consecutive business days
- 180-day compliance period ends March 16, 2027
- To regain compliance, closing bid price must be at least $1.00 for 10 consecutive business days
- A second 180-day compliance period may be available if not cured by March 16, 2027
- If compliance is not regained, Nasdaq will initiate delisting proceedings with an appeal option to a hearings panel
- Stock continues trading on Nasdaq Capital Market under symbol FLNA during the cure period
Financial Impact
Delisting risk could reduce institutional ownership and liquidity significantly; no financial figures provided in the filing
Risk Factors
- Failure to regain compliance by March 16, 2027 could lead to delisting from Nasdaq
- Delisting would severely reduce institutional ownership and liquidity
- No specific remediation plan disclosed beyond general monitoring
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-030751 |
| Document: 0001437749-26-030751-index-headers.html | 0001437749-26-030751 |
| Document: 0001437749-26-030751-index.html | 0001437749-26-030751 |
| Document: 0001437749-26-030751.txt | 0001437749-26-030751 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 7d ago | 8-K | $0.6885 | awaiting T+20 | — | $0.6470 (−6.03%) |
Sep 22, 2026 5w ago | 8-K | $1.03 $0.6900 | ▼ −33.01% | ▼ −32.45% | $0.6470 (−37.18%) |
Sep 18, 2026 5w ago | 8-K | $0.7395 $0.6820 | ▲ +7.78% | ▲ +6.87% | $0.6470 (+12.51%) |
Jul 29, 2026 12w ago | 8-K | $0.8696 $0.9244 | ▲ +6.30% | ▲ +1.28% | $0.6470 (−25.60%) |
Jun 15, 2026 19w ago | 8-K | $1.21 $1.15 | ▼ −4.96% | ▼ −4.21% | $0.6470 (−46.53%) |
May 7, 2026 24w ago | 8-K | $1.36 $1.36 | · 0.00% | ▲ +3.14% | $0.6470 (+52.43%) |
May 7, 2026 24w ago | Press Release | $1.36 $1.36 | · 0.00% | ▼ −3.14% | $0.6470 (−52.43%) |
Mar 12, 2026 32w ago | Press Release | $1.95 $1.64 | ▲ +15.90% | ▲ +17.87% | $0.6470 (+66.82%) |
Mar 10, 2026 33w ago | 8-K | $2.38 $1.70 | ▼ −28.57% | ▼ −28.42% | $0.6470 (−72.82%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers